Location: Home
  • search
  • go
  • Relate News
  • 2/22/2022Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...
  • 2/22/2022State Council Issues New Plan on Senior Population Development and Eld...
  • 2/21/2022245 Listed MedPharm Cos Release 2021 Performance Guidance and Results ...
  • 2/21/2022Is China's Healthcare Industry the Next Regulatory Flashpoint under Bi...
  • 2/21/2022Why Patient-Centric Innovation Holds the Key to Long-Term Business Suc...
  • 2/21/2022Inter-Provincial Pacts on Bulk-Buying Drugs Are on the Rise in China, ...
  • 2/21/2022Cross-border Medical Data Compliance in New Era of Regulation
  • 2/21/2022Trends in China's Investigational New Drug Applications (PharmCube)
  • 2/21/2022PharmaDJ's China NMPA Approval Tracker: JAK Inhibitors Take Center Sta...
  • 2/18/2022CDE Issues the Technical Guidelines for Study on Mixing Uniformity and...
  • 2/18/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guideline ICH E...
  • 2/18/2022CDE Solicits Comments on the Draft Guidelines for Drug Registration Ac...
  • 2/18/2022Recent Executive Moves
  • 2/18/2022Drug R&D and Product Registration News Digest February 2022 (2)
  • 2/17/2022Novartis Eyes China Potential as Part of Its Strategy to Offset Billio...
  • 2/17/2022Innovent Ready to Challenge Amgen and Sanofi in PCSK9 Inhibitor Market...
  • 2/17/2022Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...
  • 2/17/2022Chinese Pharmaceutical Cross-Border M&A in 2022 (PharmExec)
  • 2/16/2022FDA Places Phase 1 Trial of Legend's Early-stage CAR-T on Hold
  • 2/16/2022SciNeuro and Alamar Collaborate to Discover Novel Therapeutic Antibodi...
  • 2/16/2022Organon Acquires Bayer's Contraceptive Products Marvelon and Mercilo...
  • 2/16/2022USTR: China Falling Short on WTO Compliance and New Trade Tools Are N...
  • 2/16/2022Information Collection on the 7th VBP Officially Initiated by the JPO
  • 2/16/2022CDE Issues the Technical Guidelines on Clinical Trial of Antiviral The...
  • 2/15/2022Snapshot of MNC Pharma's China Performance in 2021
  • 2/15/2022Moderna Announces Plan to Expand Footprint in Asia with Four Additiona...
  • 2/15/2022China Faces Fresh Health Crisis as Experts Discover Alarming Heart Con...
  • 2/15/2022ChinaBio Partnering Forum Acquired by EBD Group/Informa
  • 2/15/2022Lacking Revenue, Lepu Biopharma Chases IPO to Revive War Chest (The Ba...
  • 2/14/2022Chinese Drug Developers Look to Enter the U.S. Market through Out-lice...
  • Page:198/824 Total number of articles:24694: [First][<<] [196] [197] [198] [199] [200] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group